Medical expert of the article
New publications
Eales disease: causes, symptoms, diagnosis, treatment
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Illza disease (juvenile angiopathy) is a heterogeneous disease that can be attributed to both vascular and inflammatory (perivasculitis, vasculitis, periphlebitis). Characteristic features are recurrent vitreous hemorrhage and neovascularization of the retina on the periphery without any typical clinical signs. Neovascularization is usually noted at the border between the normal retina and the ischemic zone with poor blood supply. Men are more often ill at the age of 15-45 years.
Ophthalmoscopically: many veins of the retina are enlarged, twisted and enveloped by exudate clutches, near to many newly formed vessels. Couplings spread along the veins to the arteriovenous junction. Possible point and plamid hemorrhages in the retina of the aneurysms of the capillaries, as well as widespread preretinal hemorrhages.
[Symptoms of Illza disease
Illza disease usually persists for many years, gradually fading. Clinically, three subtypes of periphylebite are distinguished: exudative form with couplings, retinal edema, preretinal exudate; hemorrhagic form with multiple hemorrhages in the retina and vitreous body; proliferative form with newly formed vessels in the retina and vascular growth in the vitreous humor, striae and membranes in the vitreous body, secondary traction retina detachment.
What do need to examine?
How to examine?
Treatment of Illza disease
Treatment of Ilza's disease is systemic and surgical depending on the clinical manifestations of the disease. Corticosteroids are systemically used, but the positive effect of their use is unstable. Laser and photocoagulation is performed to reduce and prevent neovascularization in the vitreous, traction (tension by fibrous strands), and retinal detachment. Vitrectomy is performed in the presence of massive hemorrhages in the vitreous body and vitreoretinalnyh cords.
The prognosis regarding vision is poor. Complications include vitreous hemorrhage, cataracts, papillitis, secondary glaucoma, traction and rheumatogenic retinal detachment, iris rumenosis.